Skip to main content
. 2018 Aug 7;20(4):592–598. doi: 10.22074/cellj.2019.5370

Table 1.

Patients’ characteristics


Patient Age (Y) Sex ALS onset ALS duration (months from diagnosis) PEG (months from injection) Tracheostomy (months from injection)

1 50 Male Limb 18 8 10
2 59 Male Bulbar 6 N/A N/A
3 60 Female Limb 18 N/A N/A
4 35 Female Limb 6 N/A N/A
5 34 Female Limb 10 N/A N/A
6 57 Female Limb 12 N/A N/A
7 51 Male Bulbar 6 N/A N/A
8 54 Male Bulbar 6 N/A N/A
9 53 Male Bulbar 30 N/A N/A
10 57 Female Limb 48 N/A N/A
11 31 Male Limb 12 N/A N/A
12 42 Male Limb 9 N/A N/A
13 39 Male Limb 24 4 4
14 24 Male Limb 24 N/A N/A

N/A; Not applicable, ALS; Amyotrophic lateral sclerosis, and PEG; Percutaneous endoscopic gastrostomy.

HHS Vulnerability Disclosure